Settlements Worth $86M OK'd In Drug Price-Fixing MDL

By Matthew Santoni (May 11, 2022, 9:39 PM EDT) -- Deals for three generic-drug companies to fork over a combined $86 million to direct purchasers and indirect resellers to settle price-fixing allegations gained preliminary approval from a Philadelphia federal judge Wednesday.

In a pair of rulings, U.S. District Judge Cynthia M. Rufe granted class certification and preliminary approval for direct buyers in the $85 million settlement with Sun Pharmaceutical Industries Inc. and Taro Pharmaceuticals USA Inc. and for a $1 million settlement between indirect resellers and Breckenridge Pharmaceutical Inc.

"All of the members of the settlement class share a common interest in proving the settling defendants' alleged anticompetitive conduct, and all...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!